US FDA’s Small Adcomm For Eisai/Biogen's Leqembi Suggests Gaps In Conflict-Of-Interest Screening

 
• By Sue Sutter
  
Gap in bridge
The FDA's conflict-of-interest screening process may have some gaps. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers